Osteopontin has a protective role in prostate tumor development in mice

European Journal of Immunology

Volumn 46, Issue 11, 2016, Pages 2669-2678

  Danzaki, Keiko ^a   Kanayama, Masashi ^a   Alcazar, Oscar ^a   Shinohara, Mari L ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

B16 cell; Cancer; Cell migration; Chemokines; NK cell; Osteopontin (OPN); TRAMP; Tumor immunology

Indexed keywords

OSTEOPONTIN;

ADAPTIVE IMMUNITY; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GRAFT; CANCER INHIBITION; CELL INFILTRATION; CELL MIGRATION; CELL MIGRATION ASSAY; HISTOLOGY; IN VIVO STUDY; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; TRANSGENIC MOUSE; TUMOR GROWTH; TUMOR IMMUNOLOGY; ADENOCARCINOMA; ANIMAL; C57BL MOUSE; CANCER TRANSPLANTATION; CARCINOGENESIS; CELL MOTION; CELL PROLIFERATION; DISEASE MODEL; EXPERIMENTAL MELANOMA; GENETICS; IMMUNOLOGY; PATHOLOGY; PHYSIOLOGY; PROSTATE TUMOR; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ADAPTIVE IMMUNITY; ADENOCARCINOMA; ANIMALS; CARCINOGENESIS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; KILLER CELLS, NATURAL; MALE; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEOPLASM TRANSPLANTATION; OSTEOPONTIN; PROSTATIC NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 84990174930     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201646391     Document Type: Article

References (40)

1. Uede, T., Osteopontin, intrinsic tissue regulator of intractable inflammatory diseases. Pathol. Int. 2011. 61: 265–280.
2. Inoue, M. and Shinohara, M. L., Intracellular osteopontin (iOPN) and immunity. Immunol. Res. 2011. 49: 160–172.
3. Kanayama, M., Kurotaki, D., Morimoto, J., Asano, T., Matsui, Y., Nakayama, Y., Saito, Y. et al., Alpha9 integrin and its ligands constitute critical joint microenvironments for development of autoimmune arthritis. J. Immunol. 2009. 182: 8015–8025.
4. Cantor, H. and Shinohara, M. L., Regulation of T-helper-cell lineage development by osteopontin: the inside story. Nat. Rev. Immunol. 2009. 9: 137–141.
5. Hur, E. M., Youssef, S., Haws, M. E., Zhang, S. Y., Sobel, R. A. and Steinman, L., Osteopontin-induced relapse and progression of autoimmune brain disease through enhanced survival of activated T cells. Nat. Immunol. 2007. 8: 74–83.
6. Kitamura, M., Iwabuchi, K., Kitaichi, N., Kon, S., Kitamei, H., Namba, K., Yoshida, K. et al., Osteopontin aggravates experimental autoimmune uveoretinitis in mice. J. Immunol. 2007. 178: 6567–6572.
7. McAllister, S. S., Gifford, A. M., Greiner, A. L., Kelleher, S. P., Saelzler, M. P., Ince, T. A., Reinhardt, F. et al., Systemic endocrine instigation of indolent tumor growth requires osteopontin. Cell 2008. 133: 994–1005.
8. Iqbal, J., McRae, S., Banaudha, K., Mai, T. and Waris, G., Mechanism of hepatitis C virus (HCV)-induced osteopontin and its role in epithelial to mesenchymal transition of hepatocytes. J. Biol. Chem. 2013. 288: 36994–37009.
9. Sato, T., Nakai, T., Tamura, N., Okamoto, S., Matsuoka, K., Sakuraba, A., Fukushima, T. et al., Osteopontin/Eta-1 upregulated in Crohn's disease regulates the Th1 immune response. Gut 2005. 54: 1254–1262.
10. Sharon, Y., Raz, Y., Cohen, N., Ben-Shmuel, A., Schwartz, H., Geiger, T. and Erez, N., Tumor-derived Osteopontin reprograms normal mammary fibroblasts to promote inflammation and tumor growth in breast cancer. Cancer. Res. 2015. 75: 963–973.
11. Chiodoni, C., Colombo, M. P. and Sangaletti, S., Matricellular proteins: from homeostasis to inflammation, cancer, and metastasis. Cancer. Metastasis. Rev. 2010. 29: 295–307.
12. Kluger, H. M., Hoyt, K., Bacchiocchi, A., Mayer, T., Kirsch, J., Kluger, Y., Sznol, M. et al., Plasma markers for identifying patients with metastatic melanoma. Clin. Cancer. Res. 2011. 17: 2417–2425.
13. Bellahcene, A., Castronovo, V., Ogbureke, K. U., Fisher, L. W. and Fedarko, N. S., Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer. Nat. Rev. Cancer 2008. 8: 212–226.
14. Chong, H. C., Tan, C. K., Huang, R. L. and Tan, N. S., Matricellular proteins: a sticky affair with cancers. J Oncol 2012. 2012: 351089.
15. Thalmann, G. N., Sikes, R. A., Devoll, R. E., Kiefer, J. A., Markwalder, R., Klima, I., Farach-Carson, C. M. et al., Osteopontin: possible role in prostate cancer progression. Clin. Cancer. Res. 1999. 5: 2271–2277.
16. Hsieh, Y. H., Margaret Juliana, M., Ho, K. J., Kuo, H. C., van der Heyde, H., Elmets, C. and Chang, P. L., Host-derived osteopontin maintains an acute inflammatory response to suppress early progression of extrinsic cancer cells. Int. J. Cancer 2012. 131: 322–333.
17. Crawford, H. C., Matrisian, L. M. and Liaw, L., Distinct roles of osteopontin in host defense activity and tumor survival during squamous cell carcinoma progression in vivo. Cancer. Res. 1998. 58: 5206–5215.
18. Bourassa, B., Monaghan, S. and Rittling, S. R., Impaired anti-tumor cytotoxicity of macrophages from osteopontin-deficient mice. Cell. Immunol. 2004. 227: 1–11.
19. Greenberg, N. M., DeMayo, F., Finegold, M. J., Medina, D., Tilley, W. D., Aspinall, J. O., Cunha, G. R. et al., Prostate cancer in a transgenic mouse. Proc. Natl. Acad. Sci. U. S. A. 1995. 92: 3439–3443.
20. Donkor, M. K., Sarkar, A., Savage, P. A., Franklin, R. A., Johnson, L. K., Jungbluth, A. A., Allison, J. P. et al., T cell surveillance of oncogene-induced prostate cancer is impeded by T cell-derived TGF-beta1 cytokine. Immunity 2011. 35: 123–134.
21. Chakraborty, G., Jain, S. and Kundu, G. C., Osteopontin promotes vascular endothelial growth factor-dependent breast tumor growth and angiogenesis via autocrine and paracrine mechanisms. Cancer. Res. 2008. 68: 152–161.
22. Wai, P. Y., Guo, L., Gao, C., Mi, Z., Guo, H. and Kuo, P. C., Osteopontin inhibits macrophage nitric oxide synthesis to enhance tumor proliferation. Surgery 2006. 140: 132–140.
23. Liu, G., Lu, S., Wang, X., Page, S. T., Higano, C. S., Plymate, S. R., Greenberg, N. M. et al., Perturbation of NK cell peripheral homeostasis accelerates prostate carcinoma metastasis. J. Clin. Invest. 2013. 123: 4410–4422.
24. Chakraborty, G., Jain, S., Behera, R., Ahmed, M., Sharma, P., Kumar, V. and Kundu, G. C., The multifaceted roles of osteopontin in cell signaling, tumor progression and angiogenesis. Curr. Mol. Med. 2006. 6: 819–830.
25. Inoue, M., Moriwaki, Y., Arikawa, T., Chen, Y. H., Oh, Y. J., Oliver, T. and Shinohara, M. L., Cutting edge: critical role of intracellular osteopontin in antifungal innate immune responses. J. Immunol. 2011. 186: 19–23.
26. Inoue, M., Arikawa, T., Chen, Y. H., Moriwaki, Y., Price, M., Brown, M., Perfect, J. R. et al., T cells down-regulate macrophage TNF production by IRAK1-mediated IL-10 expression and control innate hyperinflammation. Proc. Natl. Acad. Sci. U. S. A. 2014. 111: 5295–5300.
27. Inoue, M. and Shinohara, M. L., Cutting Edge: Role of osteopontin and integrin alphav in T cell-mediated anti-inflammatory responses in endotoxemia. J. Immunol. 2015. 194: 5595–5598.
28. Zou, C., Luo, Q., Qin, J., Shi, Y., Yang, L., Ju, B. and Song, G., Osteopontin promotes mesenchymal stem cell migration and lessens cell stiffness via integrin beta1, FAK, and ERK pathways. Cell Biochem. Biophys. 2013. 65: 455–462.
29. Zhu, B., Suzuki, K., Goldberg, H. A., Rittling, S. R., Denhardt, D. T., McCulloch, C. A. and Sodek, J., Osteopontin modulates CD44-dependent chemotaxis of peritoneal macrophages through G-protein-coupled receptors: evidence of a role for an intracellular form of osteopontin. J. Cell. Physiol. 2004. 198: 155–167.
30. Leavenworth, J. W., Verbinnen, B., Wang, Q., Shen, E. and Cantor, H., Intracellular osteopontin regulates homeostasis and function of natural killer cells. Proc. Natl. Acad. Sci. U. S. A. 2015. 112: 494–499.
31. Christensen, B., Kazanecki, C. C., Petersen, T. E., Rittling, S. R., Denhardt, D. T. and Sorensen, E. S., Cell type-specific post-translational modifications of mouse osteopontin are associated with different adhesive properties. J. Biol. Chem. 2007. 282: 19463–19472.
32. Weber, G. F., Molecular mechanisms of metastasis. Cancer. Lett. 2008. 270: 181–190.
33. Mi, Z., Bhattacharya, S. D., Kim, V. M., Guo, H., Talbot, L. J. and Kuo, P. C., Osteopontin promotes CCL5-mesenchymal stromal cell-mediated breast cancer metastasis. Carcinogenesis. 2011. 32: 477–487.
34. Song, G., Ouyang, G., Mao, Y., Ming, Y., Bao, S. and Hu, T., Osteopontin promotes gastric cancer metastasis by augmenting cell survival and invasion through Akt-mediated HIF-1alpha up-regulation and MMP9 activation. J. Cell. Mol. Med. 2009. 13: 1706–1718.
35. Zhang, Z. X., Shek, K., Wang, S., Huang, X., Lau, A., Yin, Z., Sun, H. et al., Osteopontin expressed in tubular epithelial cells regulates NK cell-mediated kidney ischemia reperfusion injury. J. Immunol. 2010. 185: 967–973.
36. Kim, G. G., Donnenberg, V. S., Donnenberg, A. D., Gooding, W. and Whiteside, T. L., A novel multiparametric flow cytometry-based cytotoxicity assay simultaneously immunophenotypes effector cells: comparisons to a 4 h 51Cr-release assay. J. Immunol. Methods 2007. 325: 51–66.
37. Ou-Yang, C. W., Zhu, M., Fuller, D. M., Sullivan, S. A., Chuck, M. I., Ogden, S., Li, Q. J. et al., Role of LAT in the granule-mediated cytotoxicity of CD8 T cells. Mol. Cell Biol. 2012. 32: 2674–2684.
38. Fehniger, T. A., Cai, S. F., Cao, X., Bredemeyer, A. J., Presti, R. M., French, A. R. and Ley, T. J., Acquisition of murine NK cell cytotoxicity requires the translation of a pre-existing pool of granzyme B and perforin mRNAs. Immunity 2007. 26: 798–811.
39. Shinohara, M. L., Lu, L., Bu, J., Werneck, M. B., Kobayashi, K. S., Glimcher, L. H. and Cantor, H., Osteopontin expression is essential for interferon-alpha production by plasmacytoid dendritic cells. Nat. Immunol. 2006. 7: 498–506.
40. Shinohara, M. L., Jansson, M., Hwang, E. S., Werneck, M. B., Glimcher, L. H. and Cantor, H., T-bet-dependent expression of osteopontin contributes to T cell polarization. Proc. Natl. Acad. Sci. U. S. A. 2005. 102: 17101–17106.